MIRA Pharmaceuticals (MIRA) Competitors $1.04 +0.05 (+4.61%) Closing price 04:00 PM EasternExtended Trading$1.04 +0.00 (+0.48%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA vs. PMVP, ASRT, ADVM, KRON, IKNA, MDCX, DTIL, BYSI, MIST, and FBLGShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include PMV Pharmaceuticals (PMVP), Assertio (ASRT), Adverum Biotechnologies (ADVM), Kronos Bio (KRON), Ikena Oncology (IKNA), Medicus Pharma (MDCX), Precision BioSciences (DTIL), BeyondSpring (BYSI), Milestone Pharmaceuticals (MIST), and FibroBiologics (FBLG). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. PMV Pharmaceuticals Assertio Adverum Biotechnologies Kronos Bio Ikena Oncology Medicus Pharma Precision BioSciences BeyondSpring Milestone Pharmaceuticals FibroBiologics MIRA Pharmaceuticals (NASDAQ:MIRA) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Do institutionals and insiders believe in MIRA or PMVP? 35.2% of MIRA Pharmaceuticals shares are owned by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are owned by institutional investors. 6.7% of MIRA Pharmaceuticals shares are owned by insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community prefer MIRA or PMVP? PMV Pharmaceuticals received 21 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 63.16% of users gave PMV Pharmaceuticals an outperform vote. CompanyUnderperformOutperformMIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo VotesPMV PharmaceuticalsOutperform Votes2463.16% Underperform Votes1436.84% Do analysts rate MIRA or PMVP? MIRA Pharmaceuticals presently has a consensus price target of $14.00, indicating a potential upside of 1,246.15%. PMV Pharmaceuticals has a consensus price target of $5.67, indicating a potential upside of 444.87%. Given MIRA Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe MIRA Pharmaceuticals is more favorable than PMV Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33PMV Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Does the media refer more to MIRA or PMVP? In the previous week, MIRA Pharmaceuticals had 2 more articles in the media than PMV Pharmaceuticals. MarketBeat recorded 2 mentions for MIRA Pharmaceuticals and 0 mentions for PMV Pharmaceuticals. PMV Pharmaceuticals' average media sentiment score of 0.00 beat MIRA Pharmaceuticals' score of -0.29 indicating that PMV Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment MIRA Pharmaceuticals Neutral PMV Pharmaceuticals Neutral Which has more risk & volatility, MIRA or PMVP? MIRA Pharmaceuticals has a beta of 2.05, suggesting that its stock price is 105% more volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Is MIRA or PMVP more profitable? PMV Pharmaceuticals' return on equity of -24.20% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MIRA PharmaceuticalsN/A -337.44% -280.58% PMV Pharmaceuticals N/A -24.20%-21.67% Which has preferable valuation and earnings, MIRA or PMVP? MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than PMV Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMIRA PharmaceuticalsN/AN/A-$11.98M-$0.52-2.00PMV PharmaceuticalsN/AN/A-$68.96M-$1.14-0.91 SummaryPMV Pharmaceuticals beats MIRA Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.49M$6.66B$5.44B$7.81BDividend YieldN/A3.20%5.44%4.31%P/E Ratio-1.867.1622.2718.38Price / SalesN/A238.87389.68101.37Price / CashN/A65.6738.2034.62Price / Book3.476.266.664.18Net Income-$11.98M$142.48M$3.21B$247.71M7 Day Performance10.77%7.90%5.64%6.44%1 Month Performance-14.75%-6.03%-4.50%-3.14%1 Year Performance15.56%-1.02%17.69%5.40% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals2.4479 of 5 stars$1.04+4.6%$14.00+1,246.2%+14.3%$17.49MN/A-1.862PMVPPMV Pharmaceuticals2.7338 of 5 stars$1.10+7.8%$5.67+415.2%-36.1%$57.13MN/A-1.1050ASRTAssertio1.3761 of 5 stars$0.59-2.6%$2.75+362.6%-27.2%$56.94M$124.96M-0.8120News CoverageGap DownADVMAdverum Biotechnologies3.7249 of 5 stars$2.73-6.8%$25.83+846.3%-70.9%$56.79M$1M-0.46190Insider TradeKRONKronos Bio3.5798 of 5 stars$0.91+1.9%$1.63+79.6%-10.3%$55.18M$9.85M-0.63100Gap UpIKNAIkena Oncology3.2991 of 5 stars$1.14+2.7%$3.00+163.2%-6.2%$55.01M$659,000.00-0.9370Positive NewsMDCXMedicus PharmaN/A$4.06+1.5%$12.00+195.6%N/A$54.47MN/A0.00N/AGap UpDTILPrecision BioSciences3.8838 of 5 stars$5.13+2.2%$37.67+634.2%-44.0%$54.12M$68.70M85.51200BYSIBeyondSpringN/A$1.34+2.3%N/A-32.5%$54.02M$1.88M0.0080Gap UpMISTMilestone Pharmaceuticals1.0763 of 5 stars$1.01+13.6%$17.00+1,583.2%-24.6%$53.89M$1M-1.2530High Trading VolumeFBLGFibroBiologics1.4849 of 5 stars$1.38+16.0%$13.00+842.0%-88.8%$52.07MN/A-4.0610Gap Up Related Companies and Tools Related Companies PMV Pharmaceuticals Competitors Assertio Competitors Adverum Biotechnologies Competitors Kronos Bio Competitors Ikena Oncology Competitors Medicus Pharma Competitors Precision BioSciences Competitors BeyondSpring Competitors Milestone Pharmaceuticals Competitors FibroBiologics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
